Matches in SemOpenAlex for { <https://semopenalex.org/work/W2944896535> ?p ?o ?g. }
- W2944896535 endingPage "44" @default.
- W2944896535 startingPage "34" @default.
- W2944896535 abstract "Background. Low-grade gliomas are the most common brain tumors in children. Gliomas have a favorable prognosis, but in some cases relapses or continued tumor growth occur. With relatively similar clinical and morphological characteristics of tumors, it is rather difficult to select a group of patients who may have progression. Objective. Our aim was to study the impact of certain clinical, histological and molecular characteristics of tumors on the progression/recurrence. Methods. A retrospective cohort study was carried out. Clinical data, histological features and molecular markers (overexpression of phosphorylated ERK1/2 (pERK1/2), mutation of B-Raf kinase (BRAF V600E), deletion of CDKN2A gene (delCDKN2A) were studied in 90 patients with low-grade pediatric gliomas, who were treated in the Center for Pediatric Oncology, Hematology and Immunology during 2010–2018. In gliomas with signs of anaplasia expression of gene of the X-linked alpha-thalassemia syndrome (ATRX), a trymethylated form of histone 3 (H3K27me), p53, and mutation of the dehydrogenase 1 isocitrate 1 gene (IDH1R132H) were also evaluated. Immunohistochemistry and the hybridization in situ (FISH) was performed to evaluate the molecular markers. Results. Statistical analysis confirmed the importance of such factors as non-radical tumor removal (p<0.0001), repeated treatment (p<0.0025), overexpression of pERK1/2 (p<0.0001), histological signs of anaplasia (p<0.0022), areas of diffuse growth (p<0.001), BRAF V600E (p<0.0001), delCDKN2A (p<0.0099). In tissue of gliomas with anaplasia overexpression of pERK1/2, mutation BRAF V600E, delCDKN2A and ATRX loss were more common. When conducting multivariate analysis, non-radical tumor removal and the presence of one of the molecular markers significantly influenced the prognosis (p<0.0001). Conclusion. The definition of molecular markers and the simultaneous assessment of the degree of tumor resection allows us to distinguish a group of patients with a high risk of tumor recurrence / progression." @default.
- W2944896535 created "2019-05-29" @default.
- W2944896535 creator A5013255709 @default.
- W2944896535 creator A5028538485 @default.
- W2944896535 creator A5055474179 @default.
- W2944896535 creator A5071842464 @default.
- W2944896535 date "2019-04-15" @default.
- W2944896535 modified "2023-09-26" @default.
- W2944896535 title "The Clinical Significance of Molecular Markers — BRAF V600E Mutations and CDKN2A Deletions — in Low-Grade Pediatric Gliomas: Cohort Study" @default.
- W2944896535 cites W1574065726 @default.
- W2944896535 cites W1973566219 @default.
- W2944896535 cites W1981568139 @default.
- W2944896535 cites W2017183045 @default.
- W2944896535 cites W2021448795 @default.
- W2944896535 cites W2028906953 @default.
- W2944896535 cites W2049487259 @default.
- W2944896535 cites W2051426927 @default.
- W2944896535 cites W2065155886 @default.
- W2944896535 cites W2078971030 @default.
- W2944896535 cites W2100130667 @default.
- W2944896535 cites W2103040128 @default.
- W2944896535 cites W2115078134 @default.
- W2944896535 cites W2123953071 @default.
- W2944896535 cites W2124187900 @default.
- W2944896535 cites W2129554457 @default.
- W2944896535 cites W2146267855 @default.
- W2944896535 cites W2154176599 @default.
- W2944896535 cites W2160382843 @default.
- W2944896535 cites W2318276835 @default.
- W2944896535 cites W2603211472 @default.
- W2944896535 cites W2889619176 @default.
- W2944896535 cites W4210738594 @default.
- W2944896535 doi "https://doi.org/10.15690/onco.v6i1/1996" @default.
- W2944896535 hasPublicationYear "2019" @default.
- W2944896535 type Work @default.
- W2944896535 sameAs 2944896535 @default.
- W2944896535 citedByCount "0" @default.
- W2944896535 crossrefType "journal-article" @default.
- W2944896535 hasAuthorship W2944896535A5013255709 @default.
- W2944896535 hasAuthorship W2944896535A5028538485 @default.
- W2944896535 hasAuthorship W2944896535A5055474179 @default.
- W2944896535 hasAuthorship W2944896535A5071842464 @default.
- W2944896535 hasConcept C104317684 @default.
- W2944896535 hasConcept C121608353 @default.
- W2944896535 hasConcept C126322002 @default.
- W2944896535 hasConcept C127848430 @default.
- W2944896535 hasConcept C142724271 @default.
- W2944896535 hasConcept C143998085 @default.
- W2944896535 hasConcept C194409129 @default.
- W2944896535 hasConcept C204232928 @default.
- W2944896535 hasConcept C2776470698 @default.
- W2944896535 hasConcept C2776689207 @default.
- W2944896535 hasConcept C2778227246 @default.
- W2944896535 hasConcept C2780263296 @default.
- W2944896535 hasConcept C2780265364 @default.
- W2944896535 hasConcept C2780739268 @default.
- W2944896535 hasConcept C3019894029 @default.
- W2944896535 hasConcept C501734568 @default.
- W2944896535 hasConcept C502942594 @default.
- W2944896535 hasConcept C55493867 @default.
- W2944896535 hasConcept C71924100 @default.
- W2944896535 hasConcept C86803240 @default.
- W2944896535 hasConceptScore W2944896535C104317684 @default.
- W2944896535 hasConceptScore W2944896535C121608353 @default.
- W2944896535 hasConceptScore W2944896535C126322002 @default.
- W2944896535 hasConceptScore W2944896535C127848430 @default.
- W2944896535 hasConceptScore W2944896535C142724271 @default.
- W2944896535 hasConceptScore W2944896535C143998085 @default.
- W2944896535 hasConceptScore W2944896535C194409129 @default.
- W2944896535 hasConceptScore W2944896535C204232928 @default.
- W2944896535 hasConceptScore W2944896535C2776470698 @default.
- W2944896535 hasConceptScore W2944896535C2776689207 @default.
- W2944896535 hasConceptScore W2944896535C2778227246 @default.
- W2944896535 hasConceptScore W2944896535C2780263296 @default.
- W2944896535 hasConceptScore W2944896535C2780265364 @default.
- W2944896535 hasConceptScore W2944896535C2780739268 @default.
- W2944896535 hasConceptScore W2944896535C3019894029 @default.
- W2944896535 hasConceptScore W2944896535C501734568 @default.
- W2944896535 hasConceptScore W2944896535C502942594 @default.
- W2944896535 hasConceptScore W2944896535C55493867 @default.
- W2944896535 hasConceptScore W2944896535C71924100 @default.
- W2944896535 hasConceptScore W2944896535C86803240 @default.
- W2944896535 hasIssue "1" @default.
- W2944896535 hasLocation W29448965351 @default.
- W2944896535 hasOpenAccess W2944896535 @default.
- W2944896535 hasPrimaryLocation W29448965351 @default.
- W2944896535 hasRelatedWork W2062453374 @default.
- W2944896535 hasRelatedWork W2089236746 @default.
- W2944896535 hasRelatedWork W2137361994 @default.
- W2944896535 hasRelatedWork W2610051407 @default.
- W2944896535 hasRelatedWork W2944896535 @default.
- W2944896535 hasRelatedWork W3127921245 @default.
- W2944896535 hasRelatedWork W3197275894 @default.
- W2944896535 hasRelatedWork W4251454374 @default.
- W2944896535 hasRelatedWork W4308976893 @default.
- W2944896535 hasRelatedWork W4362595852 @default.
- W2944896535 hasVolume "6" @default.
- W2944896535 isParatext "false" @default.